#oncology
6 articles
Corporate Finance
Cardiff Oncology faces potential $500M+ valuation hit as pivotal cancer trial data looms
ViaNews Editorial Team (Finance)•
Corporate M&A
Big Pharma Bets Big on Oncology: M&A Wave and Regulatory Wins Reshape Cancer Drug Market
ViaNews Editorial Team (Finance)•
Analysis
Four Immunotherapy Companies Race Toward 2026 Launches as Next-Generation Cancer Treatments Near Market
ViaNews Editorial Team (Finance)•
Analysis
Major Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA Approvals
ViaNews Editorial Team (Finance)•